KRAMPERA, Mauro
 Distribuzione geografica
Continente #
EU - Europa 17.635
NA - Nord America 16.910
AS - Asia 11.181
SA - Sud America 1.524
AF - Africa 234
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 21
AN - Antartide 1
Totale 47.557
Nazione #
US - Stati Uniti d'America 16.551
RU - Federazione Russa 7.024
SG - Singapore 4.204
CN - Cina 3.867
GB - Regno Unito 3.463
IT - Italia 1.599
BR - Brasile 1.235
DE - Germania 1.098
HK - Hong Kong 985
SE - Svezia 972
FR - Francia 971
IE - Irlanda 872
FI - Finlandia 794
VN - Vietnam 764
KR - Corea 373
UA - Ucraina 226
IN - India 189
CA - Canada 187
JP - Giappone 168
MX - Messico 120
AR - Argentina 119
ID - Indonesia 113
BE - Belgio 99
NL - Olanda 90
PL - Polonia 86
TR - Turchia 84
ES - Italia 83
IR - Iran 78
BD - Bangladesh 71
AT - Austria 68
ZA - Sudafrica 60
IQ - Iraq 54
EC - Ecuador 50
AU - Australia 45
BJ - Benin 36
LT - Lituania 33
MA - Marocco 28
PK - Pakistan 28
UZ - Uzbekistan 27
CL - Cile 26
CO - Colombia 26
EG - Egitto 23
TG - Togo 23
VE - Venezuela 23
RO - Romania 21
MY - Malesia 20
CH - Svizzera 19
AE - Emirati Arabi Uniti 18
PY - Paraguay 18
AZ - Azerbaigian 17
KE - Kenya 17
CZ - Repubblica Ceca 16
EU - Europa 16
IL - Israele 16
PT - Portogallo 14
PE - Perù 13
BG - Bulgaria 11
CM - Camerun 11
KZ - Kazakistan 10
SA - Arabia Saudita 10
GR - Grecia 9
KG - Kirghizistan 9
PH - Filippine 9
UY - Uruguay 9
AL - Albania 8
CR - Costa Rica 8
LV - Lettonia 8
DK - Danimarca 7
PA - Panama 7
TH - Thailandia 7
TN - Tunisia 7
CG - Congo 6
DZ - Algeria 6
NI - Nicaragua 6
NO - Norvegia 6
TW - Taiwan 6
AM - Armenia 5
HN - Honduras 5
HU - Ungheria 5
JM - Giamaica 5
JO - Giordania 5
LA - Repubblica Popolare Democratica del Laos 5
RS - Serbia 5
BO - Bolivia 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
LU - Lussemburgo 4
NP - Nepal 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
CY - Cipro 3
GE - Georgia 3
KW - Kuwait 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
Totale 47.495
Città #
Southend 2.971
Moscow 2.410
Dallas 2.299
Singapore 1.988
Jacksonville 1.958
Chandler 1.930
Ashburn 1.413
Woodbridge 1.225
Hong Kong 974
Ann Arbor 885
Dublin 865
Houston 699
Beijing 579
New York 394
Verona 363
The Dalles 355
Los Angeles 335
Jinan 324
Lawrence 314
Princeton 314
Wilmington 305
Shenyang 299
Nanjing 261
Munich 249
Ho Chi Minh City 248
Buffalo 170
Tianjin 164
Helsinki 155
Milan 153
São Paulo 143
Hebei 140
Hanoi 139
Sindelfingen 130
Zhengzhou 113
Changsha 107
Columbus 107
Redondo Beach 105
Turku 103
Santa Clara 101
Nanchang 97
Brussels 93
Haikou 91
Ningbo 86
Seoul 86
Düsseldorf 85
Tokyo 85
Hangzhou 83
Guangzhou 80
Redmond 79
Boardman 77
London 77
Warsaw 76
Seattle 74
Taiyuan 72
Taizhou 71
Dong Ket 70
San Francisco 67
Jiaxing 65
Montreal 64
Novosibirsk 64
Jakarta 62
Denver 61
Lancaster 59
Brooklyn 58
Chicago 55
Council Bluffs 54
Frankfurt am Main 53
Orem 53
Stockholm 53
Rome 52
Bologna 49
Atlanta 46
Norwalk 46
Chennai 45
Toronto 45
Boston 44
Johannesburg 44
Mexico City 43
Rio de Janeiro 40
Lappeenranta 39
Vienna 39
Auburn Hills 38
Fairfield 38
Lanzhou 38
Cotonou 36
Kent 35
Nuremberg 34
Phoenix 34
Dearborn 31
Falkenstein 31
Fuzhou 31
Amsterdam 29
Redwood City 29
Poplar 28
Falls Church 27
Washington 27
Belo Horizonte 26
Brasília 26
Mumbai 26
Querétaro 26
Totale 29.059
Nome #
La citometria a flusso in Ematologia: aspetti tecnici e metodologici 457
Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog 384
Valutazione immunofenotipica della malattia minima residua (MRD) nella leucemia acuta linfoblastica dell'adulto 310
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 287
Comparative Study of Immune Regulatory Properties of Stem Cells Derived from Different Tissues. 286
Risk Factors for Persisting SARS-CoV-2 Infection in Patients with B-Cell Malignancies in the Omicron Era: A Multicenter Cohort Study 276
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 276
Meninges: from protective membrane to stem cell niche 261
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 260
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 257
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 244
Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrow. 243
Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. 241
In vitro characterization of the differentiation of meningeal Stem/precursor cells into the oligodendrocyte lineage 239
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 232
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients 231
IN VITRO CHARACTERIZATION OF THE DIFFERENTIATION OF MENINGEAL STEM/PRECURSOR CELLS INTO THE OLIGODENDROCYTE LINEAGE 224
Quantitative fluorescence in situ hybridization on paraffin embedded tissue. 224
Molecular characterization of msc-derived extracellular vesicles and correlation with their immunomodulatory potential 224
Notch singalling inhibition as a multi-target therapy to overcome bone marrow microenvironment-mediated drug resistance in AML 223
Meninges as a niche for stem/precursor cells with neural differentiation potential during development up to adulthood. 222
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 222
A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. 219
Migration of meningeal cells in response to contusive spinal cord injury 217
Role of GSK-3 signalling in non-promyelocitic acute myeloid leukemia (AML) cell response to chemotherapy 217
Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus 215
Adult spinal cord meninges: A new source of neural stem cells 215
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy 215
Analisi del riarrangiamento bcr-abl in alcuni pazienti affetti da leucemia mieloide cronica 213
Adipose-derived stromal cells (ASCs) 212
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 211
Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy 211
Adipose derived mesenchimal stem cells and CNS: differentiation potential and immune suppression 210
In vitro characterization of the differentiation of meningeal stem/precursor cells into the oligodendrocyte lineage 204
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 204
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 203
Inhibition of GSK-3 Signalling Enhances Sensitivity of Non-Promyelocitic Acute Myeloid Leukemia (AML) Cell to Chemotherapy 203
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 202
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. 200
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 198
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 197
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 196
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 195
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche 195
Domanda di brevetto per modello di utilità nr. TO2010U000026 depositata il 23 Febbraio 2010 dal titolo: "DISPOSITIVO PER LA COLTURA CELLULARE", poi convertito in brevetto modello nazionale (nr. 272134) ed internazionale (PCT/IB2011/000365). 194
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions 193
Acute Myeloid Leukemia (AML) after BMT in a patient with Acute T-Lymphoblastic Leukemia (T-ALL) in CR, with no detectable minimal residual disease by flow-cytometry 191
Clinical treatment of radiotherapy tissue damages by lipoaspirates transplant: a healing process mediated by adipose-derived adult stem cells (ASCs) 190
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 188
Rational of targeting WNT/beta-catenin signaling in acute myeloid leukemia (AML) 188
Caratterizzazione immunofenotipica: principi ed applicazioni in Ematologia 186
A murine model for the study of the inhibitory effect on antigen-specific naïve and memory T cells by bone marrow mesenchymal stem cells 184
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 184
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 184
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 183
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 182
CHARACTERIZATION OF MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLES AND CORRELATION WITH THEIR IMMUNOSUPPRESSIVE PROPERTIES TOWARDS B CELLS 180
Meninges harbor cells expressing neural precursor markers during development and adulthood 179
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 175
Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton 174
Guided differentiation of MSCs for regeneration of perimplant bone 173
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations 173
Regenerative potential of leptomeningeal-derived oligodendrocytes in rat model of spinal cord injury 172
Chapter 4: Mesenchymal stem cell isolation and expansion methodology. In: Stem Cells And Cancer Stem Cells: Therapeutic Applications in Disease and Injury 171
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 171
Effects of a Ceramic Biomaterial on Immune Modulatory Properties and Differentiation Potential of Human Mesenchymal Stromal Cells of Different Origin. 171
Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice 170
Normal hematopoiesis and hematologic malignancies: role of canonical Wnt signaling pathway and stromal microenvironment 170
The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia 169
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 169
Bone marrow-, spleen- and thymus-derived mesenchymal stem cells favour the growth of myeloma cells in a mouse model 169
Bone marrow mesenchymal stem cells express HER-1 and are sensitive to the effect of HB-EGF 169
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 169
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 168
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 168
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 167
Immune Modulation by Mesenchymal Stem Cells 166
Preventive and therapeutic beneficial effect of adipose-derived mesenchymal stem cells in chronic EAE 166
Adipose-derived mesenchymal stem cells maintains their stem profile with aging. 166
Differentiation of mature oligodendrocytes from small biopsy of adult rat spinal cord meninges 166
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 166
P21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin’s lymphomas and Hodgkin’s disease: a reliable marker of p53 tumor suppressor gene function 166
Computer-based drug management in a bone marrow transplant unit: a suitable tool for multiple prescriptions even in critical conditions 165
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 163
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 163
Bone marrow-derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T acute lymphoblastic leukaemia: the role of interleukin 7 162
Stem molecular signature of adipose-derived stromal cells. 162
Homing and migration of transplanted leptomeningeal stem/progenitor cells in adult rat brain 162
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 162
Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia 162
Adult T-cell acute lymphoblastic leucemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol 161
Multipotent stem cell with neural differentiation potential reside in the leptomeninges 161
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 160
Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies? 160
Inhibition of Notch signaling enhances chemosensitivity in B cell precursor acute lymphoblastic leukemia 160
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia patients 160
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia 160
Assetto citochinico e pattern del CD30 durante la maturazione del sistema immunitario 159
Sequential high dose chemotherapy with PBSC rescue in advanced hematologic malignancies 157
Nestin- and Doublecortin-Positive Cells Reside in Adult Spinal CordMeninges and Participate in Injury-Induced Parenchymal Reaction 157
Totale 19.941
Categoria #
all - tutte 152.049
article - articoli 86.180
book - libri 0
conference - conferenze 62.699
curatela - curatele 0
other - altro 476
patent - brevetti 721
selected - selezionate 0
volume - volumi 1.973
Totale 304.098


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.394 0 0 0 0 0 351 47 218 203 32 358 185
2021/20222.615 304 707 38 175 120 54 31 154 102 92 234 604
2022/20235.503 405 565 509 1.047 455 1.336 30 327 569 47 133 80
2023/20243.038 110 211 257 303 339 502 191 175 33 207 475 235
2024/20257.624 440 493 360 1.202 364 277 311 300 1.210 476 712 1.479
2025/202616.285 1.538 1.741 1.872 3.848 6.354 932 0 0 0 0 0 0
Totale 47.995